Related Experiment Video

Updated: May 20, 2026

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

Effects of statins on cardiorenal syndrome

Shusuke Yagi1, Ken-Ichi Aihara, Yasumasa Ikeda

  • 1Department of Cardiovascular Medicine, The University of Tokushima Graduate School of Health Biosciences, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.

International Journal of Vascular Medicine
|July 14, 2012
PubMed

Insights

Statins may offer a new strategy for managing cardiorenal syndrome (CRS), a condition linking heart and kidney disease. Their cholesterol-lowering and pleiotropic effects show promise in preventing CRS worsening.

Area of Science:

  • Cardiology
  • Nephrology
  • Pharmacology

Background:

  • Cardiorenal syndrome (CRS) describes the cardiorenal interactions forming a detrimental cycle.
  • Established cardiovascular risk factors activate the renin-angiotensin-aldosterone system, leading to oxidative stress, endothelial dysfunction, and vascular inflammation.
  • Current management strategies for CRS remain unestablished.

Purpose of the Study:

  • To explore the potential of statins as a therapeutic strategy for cardiorenal syndrome.
  • To evaluate the pleiotropic effects of statins beyond cholesterol reduction in the context of CRS.

Main Methods:

  • Review of recent studies on statin effects in cardiovascular and renal diseases.
  • Analysis of statins' impact on oxidative stress, endothelial function, and inflammation.
  • Assessment of cholesterol-lowering-dependent and -independent mechanisms.

Main Results:

  • Statins possess cholesterol-lowering properties and exhibit pleiotropic effects, including anti-inflammatory and antioxidant actions.
  • Statins improve nitric oxide bioavailability, crucial for cardiovascular and renal health.
  • Evidence suggests statins benefit chronic kidney disease, heart failure, and coronary artery disease.

Conclusions:

  • Statins demonstrate potential therapeutic benefits for cardiorenal syndrome.
  • Their multifaceted actions may help prevent the progression of CRS.
  • Further investigation into statin therapy for CRS is warranted.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...